To include your compound in the COVID-19 Resource Center, submit it here.

EC approves label expansion for Bial-Portela's epilepsy drug Zebinix

In May, the European Commission approved a label expansion for

Read the full 105 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE